---
$id: https://graph.org.ai/products/commodity/51392213
$type: Product
source: UNSPSC
code: "51392213"
title: "Tefazoline"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tefazoline

**UNSPSC Code**: 51392213
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C14H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9738II2CCH, chemically known as 2-(5,6,7,8-tetrahydro-1-naphthyl)methyl)-2-imidazolin but generally known as tefazoline, which bears US NIH Compound Identifier 163309. European Medicines Agency schedules Tefazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10865MIG. The term TEFAZOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). TEFAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tefazoline under HS 29332990 and SITC 51573. As of Q4 2014, TEFAZOLINE remains the US FDA Preferred Term for this commodity. Tefazoline bears US NLM identifiers UMLS ID C2699906 and NCI Concept Code C75044. SMILES: N1C(=NCC1)CC1C2CCCCC2CCC1.

